Morgan Stanley’s Altamira Therapeutics Ltd CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.04K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $122 | Hold |
|
|||||
|
2023
Q2 | $321 | Sell |
|
|||||
|
2023
Q1 | $1.31K | Sell |
|
|||||
|
2022
Q4 | $12.1K | Sell |
|
|||||
|
2022
Q3 | $17K | Buy |
|
|||||
|
2022
Q2 | $13K | Buy |
|
|||||
|
2022
Q1 | $9K | Buy |
|
|||||
|
2021
Q4 | $15K | Sell |
|
|||||
|
2021
Q3 | $31K | Buy |
|
|||||
|
2021
Q2 | $46K | Hold |
|
|||||
|
2021
Q1 | $45K | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $9K | Sell |
|
|||||
|
2020
Q1 | $12K | Sell |
|
|||||
|
2019
Q4 | $42K | Buy |
|
|||||
|
2019
Q3 | $34K | Sell |
|
|||||
|
2019
Q2 | $70K | Buy |
|
|||||
|
2019
Q1 | $17K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $92K | Sell |
|
|||||
|
2018
Q2 | $411K | Buy |
|
|||||
|
2018
Q1 | $243K | Buy |
|
|||||
|
2017
Q4 | $584K | Buy |
|
|||||
|
2017
Q3 | $447K | Buy |
|
|||||
|
2017
Q2 | $265K | Buy |
|
|||||
|
2017
Q1 | $138K | Buy |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Hold |
|
|||||
|
2015
Q3 | – | Hold |
|
|||||
|
2015
Q2 | – | Hold |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Hold |
|
|||||
|
2014
Q3 | – | Hold |
|